EPSILON Financial Statements From 2010 to 2024

9TH0 Stock  EUR 0.01  0.00  0.00%   
EPSILON HEALTHCARE financial statements provide useful quarterly and yearly information to potential EPSILON HEALTHCARE LTD investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on EPSILON HEALTHCARE financial statements helps investors assess EPSILON HEALTHCARE's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting EPSILON HEALTHCARE's valuation are summarized below:
EPSILON HEALTHCARE LTD does not now have any fundamental signals for analysis.
Check EPSILON HEALTHCARE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EPSILON HEALTHCARE's main balance sheet or income statement drivers, such as , as well as many indicators such as . EPSILON financial statements analysis is a perfect complement when working with EPSILON HEALTHCARE Valuation or Volatility modules.
  
This module can also supplement various EPSILON HEALTHCARE Technical models . Check out the analysis of EPSILON HEALTHCARE Correlation against competitors.

EPSILON HEALTHCARE LTD Company Shares Outstanding Analysis

EPSILON HEALTHCARE's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current EPSILON HEALTHCARE Shares Outstanding

    
  300.35 M  
Most of EPSILON HEALTHCARE's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EPSILON HEALTHCARE LTD is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, EPSILON HEALTHCARE LTD has 300.35 M of shares currently outstending. This is 66.37% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all Germany stocks is 47.47% higher than that of the company.

EPSILON HEALTHCARE LTD Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining EPSILON HEALTHCARE's current stock value. Our valuation model uses many indicators to compare EPSILON HEALTHCARE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EPSILON HEALTHCARE competition to find correlations between indicators driving EPSILON HEALTHCARE's intrinsic value. More Info.
EPSILON HEALTHCARE LTD is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EPSILON HEALTHCARE's earnings, one of the primary drivers of an investment's value.

About EPSILON HEALTHCARE Financial Statements

EPSILON HEALTHCARE stakeholders use historical fundamental indicators, such as EPSILON HEALTHCARE's revenue or net income, to determine how well the company is positioned to perform in the future. Although EPSILON HEALTHCARE investors may analyze each financial statement separately, they are all interrelated. For example, changes in EPSILON HEALTHCARE's assets and liabilities are reflected in the revenues and expenses on EPSILON HEALTHCARE's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in EPSILON HEALTHCARE LTD. Please read more on our technical analysis and fundamental analysis pages.
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. EPSILON HEALTHCARE operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in EPSILON Stock

EPSILON HEALTHCARE financial ratios help investors to determine whether EPSILON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EPSILON with respect to the benefits of owning EPSILON HEALTHCARE security.